BX Swiss TOP 30 CHF
1.185,32
PKT
-2,74
PKT
-0,23
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.01.24 | Richemont Outperform | Bernstein Research | |
| 18.01.24 | Richemont Sector Perform | RBC Capital Markets | |
| 18.01.24 | Richemont Buy | UBS AG | |
| 18.01.24 | Richemont Buy | Jefferies & Company Inc. | |
| 17.01.24 | Swiss Re Sell | UBS AG | |
| 17.01.24 | Zurich Insurance Neutral | UBS AG | |
| 16.01.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 16.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 16.01.24 | Roche Hold | Jefferies & Company Inc. | |
| 16.01.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 15.01.24 | Roche Neutral | UBS AG | |
| 15.01.24 | Novartis Buy | UBS AG | |
| 15.01.24 | UBS Kaufen | DZ BANK | |
| 15.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 15.01.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 15.01.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 12.01.24 | Richemont Buy | Deutsche Bank AG | |
| 12.01.24 | Richemont Buy | Jefferies & Company Inc. | |
| 12.01.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 12.01.24 | Richemont Sector Perform | RBC Capital Markets | |
| 11.01.24 | UBS Outperform | RBC Capital Markets | |
| 11.01.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 11.01.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 11.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.01.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 11.01.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 10.01.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 10.01.24 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 10.01.24 | Holcim Neutral | Merrill Lynch & Co., Inc. | |
| 10.01.24 | Zurich Insurance Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.01.24 | Givaudan Market-Perform | Bernstein Research | |
| 09.01.24 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 09.01.24 | Roche Equal Weight | Barclays Capital | |
| 09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | Givaudan Market-Perform | Bernstein Research | |
| 08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Novartis Neutral | UBS AG | |
| 08.01.24 | Richemont Sector Perform | RBC Capital Markets | |
| 05.01.24 | UBS Outperform | RBC Capital Markets | |
| 05.01.24 | Novartis Buy | Deutsche Bank AG |